Publications

Filters
December 28, 2015

Efficacy and Safety Of AFN-1252, The First Staphylococcus-Specific Antibacterial Agent, in The Treatment of Acute Bacterial Skin And Skin Structure…

Read more
November 8, 2015

Clinical Safety, Pharmacokinetics and Early Evidence of Activity of The Oral IAPs Inhibitor Debio 1143 in Combination with Carboplatin and…

Read more
October 23, 2015

SMAC mimetic Debio 1143 synergizes with taxanes, topoisomerase inhibitors and bromodomain inhibitors to impede growth of lung adenocarcinoma cells

Read more
September 21, 2015

The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNF-alpha-mediated in head and neck squamous cell carcinoma.

Read more
September 19, 2015

Single Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a FabI Inhibitor, the Prodrug Debio 1450 and…

Read more
September 11, 2015

Safety, tolerability and pharmacokinetics of AFN–1252 administered as immediate release tablets in healthy subjects

Read more
July 31, 2015

Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute…

Read more
May 29, 2015

Phase I Dose-escalation Study with Extended Daily Administration of Debio 1143, an Oral Inhibitor of Apoptosis Protein Inhibitor, in Patients…

Read more
May 19, 2015

Triptorelin 6-month Formulation Shows Good Efficacy and Safety in Patients with Central Precocious Puberty (CPP)

Read more